Therapeutic effects of Neurotec on Improving Tinnitus in patients attending to Baqiyatallah Clinic
Phase 3
- Conditions
- Tinnitus.Tinnitus
- Registration Number
- IRCT2017042817413N23
- Lead Sponsor
- Vice Chancellor for Research, Baqiyatallah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion Criteria:
1- Informed consent
2- Tinnitus for at least 6 months
3- Age over 19
Exclusion criteria:
1-Pregnancy
2-Age over 75 and under 19
3-Chronic or Acute neurologic disease
4-Psychologic disease
5-Previous surgery on the affected ear
6-Pulsatile Tinnitus
7-Epilepsy
8-Multiple sclerosis
9- History of sever trauma to head and neck
10- History of treatment 1 month prior to intervention
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hearing Threshold. Timepoint: Before, one month and three months after interventin. Method of measurement: Pure Tone Audiometry.;Quality of Life. Timepoint: Before, one month and three months after interventin. Method of measurement: Tinnitus Handicap Inventory.
- Secondary Outcome Measures
Name Time Method Drug Complications. Timepoint: During study. Method of measurement: Patients' complaint.